Acetaminophen, Dextromethorphan Hbr, Guailfenesin,phenlyephrine Hcl Capsule, Liquid Filled
NDC Package 41226-628-16
Package Information
Acetaminophen, Dextromethorphan Hbr, Guailfenesin, Phenlyephrine Hcl capsules is iNDICATIONS & USAGE temporarily relieves these common cold and flu symptoms: nasal congestion - headache - cough - minor aches and pains - sore throat - temporarily reduces fever - promotes nasal and/or sinus drainage - helps . This formulation utilizes a capsule, liquid filled delivery system. Marketed by Kroger Company, this product is identified by NDC 41226-628 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1656815 - acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Capsule
- RxCUI: 1656815 - acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule
- RxCUI: 1656815 - APAP 325 MG / Dextromethorphan Hydrobromide 10 MG / Guaifenesin 200 MG / Phenylephrine Hydrochloride 5 MG Oral Capsule
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 41226 - Kroger Company
- 41226-628 - Acetaminophen, Dextromethorphan Hbr, Guailfenesin, Phenlyephrine Hcl
- 41226-628-16 - 16 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
- 41226-628 - Acetaminophen, Dextromethorphan Hbr, Guailfenesin, Phenlyephrine Hcl
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 41226-628-16 identifies a specific commercial package of 16 capsule, liquid filled in 1 blister pack of Acetaminophen, Dextromethorphan Hbr, Guailfenesin, Phenlyephrine Hcl, a human over the counter drug labeled by Kroger Company. This capsule, liquid filled is formulated for oral use and contains acetaminophen; dextromethorphan hydrobromide; guaifenesin; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kroger Company on December 21, 2020. The current certification is valid through December 31, 2026.
How is this Kroger Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 41226062816. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.